Oral arsenic trioxide therapy for acute promyelocytic leukemia before and after liver transplantation for hepatitis B virus-related liver failure.
Au
Wing-Yan
WY
Liu
Chi-Leung
CL
Tam
Sidney
S
Fong
Bonnie M W
BM
Shek
Tony W
TW
Hui
Chee-Kin
CK
Kwong
Yok-Lam
YL
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000008:administration & dosage*; D006509:Hepatitis B / Q000097:blood / Q000150:complications / Q000628:therapy*; D006515:Hepatitis B virus; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000097:blood / Q000150:complications / Q000628:therapy*; D017093:Liver Failure / Q000097:blood / Q000628:therapy*; D016031:Liver Transplantation; D008297:Male; D010087:Oxides / Q000008:administration & dosage*; D012367:RNA, Viral / Q000097:blood; D013997:Time Factors; D014184:Transplantation, Homologous; D014775:Virus Activation / Q000187:drug effects
D001152:Arsenicals; D010087:Oxides; D012367:RNA, Viral; D000077237:Arsenic Trioxide